Health News sCD14

FDA Grants Approval for Heart Attack Trial

The US Food and Drug Administration has issued a “Study May Proceed” letter approving the commencement of clinical study with IC14 in patients with the most severe form of heart attack. An ST-elevated myocardial infarction (STEMI) is a very serious type of heart attack during which one of the heart’s major arteries supplying oxygen and […]